Efficacy and Safety of Minodronate in Patients With Low Back Pain
Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
This study will provide objective evidence for the efficiency and safety of minodronate in
the treatment of postmenopausal osteoporosis with low back pain protocol. Furthermore, it
will be helpful to evaluate the quantitative relationship between bone metabolic markers
(BTM) and bone mineral density (BMD) in patients with osteoporosis under different ages.